matthias bozza
Vector BioPharma
Basel, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
Vector BioPharma
Basel, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
National Institute of Health (ISS)
Rome, Italy
Review Editor
Cancer Immunity and Immunotherapy
Department of General and Visceral Surgery, University of Freiburg Medical Center
Freiburg, Germany
Review Editor
Cancer Immunity and Immunotherapy
Intima Bioscience
Cambridge, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Celyad SA
Mont-St-Guibert, Belgium
Review Editor
Cancer Immunity and Immunotherapy
San Raffaele Hospital (IRCCS)
Milan, Italy
Review Editor
Cancer Immunity and Immunotherapy
Texas Tech University Health Sciences Center
Lubbock, United States
Review Editor
Cancer Immunity and Immunotherapy
Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Université Catholique de Louvain
Louvain-la-Neuve, Belgium
Review Editor
Cancer Immunity and Immunotherapy
University Medical Center Göttingen
Göttingen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Xcell Biosciences
San Francisco, United States
Review Editor
Cancer Immunity and Immunotherapy
INSERM U1231 Lipides, Nutrition, Cancer (LNC)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
de Duve Institute, Faculté de pharmacie et des sciences biomédicales, Université catholique de Louvain
Brussels, Belgium
Review Editor
Cancer Immunity and Immunotherapy
University of Pittsburgh
Pittsburgh, United States
Review Editor
Cancer Immunity and Immunotherapy
Augusta University
Augusta, United States
Review Editor
Cancer Immunity and Immunotherapy
University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Review Editor
Cancer Immunity and Immunotherapy